SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-22-028552
Filing Date
2022-02-07
Accepted
2022-02-04 17:36:39
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 d300356ds3.htm S-3 339760
2 EX-4.2 d300356dex42.htm EX-4.2 269135
3 EX-5.1 d300356dex51.htm EX-5.1 32637
4 EX-23.1 d300356dex231.htm EX-23.1 1768
5 EX-FILING FEES d300356dexfilingfees.htm EX-FILING FEES 54645
6 GRAPHIC g300356g0205030111956.jpg GRAPHIC 2710
  Complete submission text file 0001193125-22-028552.txt   702836
Mailing Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339
Business Address 3350 RIVERWOOD PARKWAY SE, SUITE 1900 ATLANTA GA 30339 678-392-3419
Inhibikase Therapeutics, Inc. (Filer) CIK: 0001750149 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-262551 | Film No.: 22594829
SIC: 2836 Biological Products, (No Diagnostic Substances)